These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39338323)

  • 1. Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma.
    Li X; Chen X; Yu H; Huang R; Wu P; Gong Y; Chen X; Liu C
    Pharmaceuticals (Basel); 2024 Aug; 17(9):. PubMed ID: 39338323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.
    Liu C; Huang R; Yu H; Gong Y; Wu P; Feng Q; Li X
    Phytomedicine; 2022 Aug; 103():154226. PubMed ID: 35689900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies.
    Liu C; Yu H; Li X; Gong Y; Wu P; Feng QS
    J Ethnopharmacol; 2022 Mar; 285():114913. PubMed ID: 34910953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms.
    Li X; Yu H; Gong Y; Wu P; Feng Q; Liu C
    J Ethnopharmacol; 2022 Feb; 284():114801. PubMed ID: 34748868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
    Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
    J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
    Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
    J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
    Duan ZW; Liu Y; Zhang PP; Hu JY; Mo ZX; Liu WQ; Ma X; Zhou XH; Wang XH; Hu XH; Wei SL
    J Ethnopharmacol; 2024 Sep; 331():118293. PubMed ID: 38705430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
    Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
    Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.
    Wang Y; Su L; Hu Z; Peng S; Li N; Fu H; Wang B; Wu H
    Apoptosis; 2024 Oct; 29(9-10):1429-1453. PubMed ID: 39023830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
    Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
    J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells.
    Zhu PL; Li JK; Jiang XL; Zhang SQ; Zhang Z; Wang Y; Zhang Z; Chen WQ; Yung KK
    J Ethnopharmacol; 2023 Aug; 312():116548. PubMed ID: 37100264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis.
    Yan F; Feng M; Wang X; Wang P; Xie Y; Liu X; Li W; Yang Z
    Cancer Cell Int; 2020 Nov; 20(1):540. PubMed ID: 33292207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
    Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
    J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
    Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
    Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
    Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
    Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3β/β-catenin signaling pathways: a network pharmacology-directed experimental investigation.
    Zhuang J; Mo J; Huang Z; Yan Y; Wang Z; Cao X; Yang C; Shen B; Zhang F
    Chin Med; 2023 Aug; 18(1):104. PubMed ID: 37608369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.